Protolabs to open new Twin Cities plant

Quick-turn manufacturer Protolabs (NYSE: PRLB) plans to have a new plant opened by the end of the year in the northern Minneapolis suburb of Brooklyn Park. Protolabs announced the purchase of the 152,000-square-foot facility on March 16. Financial terms of the deal were not disclosed, but county property records show the building was last sold

Complex injection molding: What you need to know

With careful planning, complex injection molding can reduce costs, optimize functionality and improve aesthetics in medical devices. Ken Glassen, Kaysun Corp.  As medical device design evolves to provide ever-improving healthcare outcomes, manufacturers are partnering with full-service, experienced complex injection molders to gain the increased design freedom and process efficiencies necessary to keep pace with medical

MD&M West: Here’s what you may have missed

MD&M West is one of the largest medical device manufacturing events in the world, so it’s easy to lose your way on the show floor. Even if you were in Anaheim, Calif., for the February 2018 event, you may have missed a lot. From Omron to Micromo to MedPlast to Apex Motion Control, WTWH Media

Zeiss launches 2D super resolution mode for Airyscan

Zeiss recently announced that it has launched its new 2D super resolution mode that delivers 12 nm lateral resolution for its Airyscan. The new mode is a 32-channel GaAsP array detector that captures more spatial information than other confocal microscopes. The 2D super resolution uses the spatial information to make an optical section of 0.2

China CFDA proposes regulatory framework for 3D-printed medical devices

Stewart Eisenhart, Emergo Group Medical device market regulators at the China Food and Drug Administration (CFDA) have published new guidance proposing registration requirements for devices produced via 3D printing or additive manufacturing. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are the author’s only and do

Webinar: The most exciting medtech of 2018

Thursday, April 5, 2018 2 p.m. Eastern time / 11 a.m. Pacific time     The medtech industry has seen some new technologies and ideas that could change the way healthcare is delivered. Much of the most exciting medtech comes from unexpected sources. Ideas include e giving patients a virtual wallet to carry their own patient

Medical device startups: Here’s how you handle regulatory and reimbursement

The two “Rs” — regulatory and reimbursement — are critical elements of the environment in which a medical device product is developed. Bill Betten, Betten Systems Solutions This is the fourth in a series of articles that discusses the design of innovative products in the highly regulated medical environment.  But the “environmental” factors of regulatory and reimbursement actually

Risk management for cloud-powered medtech: What you need to know

Cloud-enhanced medical devices are on the rise. There are some incredible benefits to the trend, as well as some increases in risk. Medtech developers should take note of the risks to properly develop a risk management strategy.  Michael Ford, Pro Back Office As we kickstart 2018, there are increasing concerns and risk challenges for the

March 2018 issue: Does Robotic Telesurgery Have a Future?

Is Amazon about to disrupt the medical device business? The word “disruption” is bandied about a lot. But if Amazon does to the medical supply and prescription drug businesses what it did to bookstores, the effects could be truly disruptive to medical markets. Think the commoditization of a wide host of medical products, including diabetes

Medical device reimbursement: How it’s a brave new world

Populations in developing countries are aging. Healthcare systems are feeling even more financial pressure. In response, there’s been a shift toward payment models in the U.S. and elsewhere that emphasize “value.” In other words, health providers need to run more efficiently and effectively to get paid. Medical device reimbursement will never be the same. “This

How to redesign medical carts to reflect changing healthcare settings

The way to redesign medical carts for better practicality and maneuverability for changing healthcare settings is making lighter power sources, according to a white paper from Accutronics. “Designs [now focus on innovative solutions to create smaller and lighter carts that are easy to maneuver,” Marty Carlos from the medical device consulting firm Paragon Group said.

FDA’s Breakthrough Device Program: It may make a difference

Dr. Malvina Eydelman, Director of the Division of Ophthalmic, and Ear, Nose, and Throat Devices, Office of Device Evaluation FDA’s Breakthrough Devices Program is beginning to show important results for patients since it was established in late 2016 under the 21st Century Cures Act to help patients gain timely access to breakthrough technologies. Consider Second Sight

8 women medtech innovators you need to know

As we celebrate more women becoming medtech leaders and paving the way for innovation, it’s important to remember the many accomplishments women have already made when it comes to the advancement of health and medicine. X-rays on the battlefield, the American Red Cross, leprosy treatment and more — these advances happened because of women. As

Pages: 1 2 3 4 5 6 7 8 9

Masimo expected to grow through 2025 as it branches out, analyst says

Masimo (Nasdaq: MASI) should enjoy growth through the middle of the next decade, thanks to its exploration of opportunities outside its core market that are more driven by hospital automation, according to a new equity research report out of Barclays. Masimo is on track to having 8–10% top-line growth and 12–15% earnings per share growth through

Optum CEO Renfro steps down to lead expanded investment fund

In a major personnel shift, UnitedHealth Group announced this week that Larry Renfro, CEO of its subsidiary Optum, will step away from the corner office to become managing partner of Optum Ventures and its expanded $600 million investment fund. Ex-GlaxoSmithKline chief executive, Andrew Witty, will take Renfro’s place as CEO of Optum on July 1,